Clinical Trials on Hormone-resistant Prostate Cancer in South Africa
Total 890 results
-
RhoVac APSActive, not recruitingProstate Cancer RecurrentSweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
-
Peter MacCallum Cancer Centre, AustraliaUnknownProstate CancerAustralia, New Zealand
-
Peter MacCallum Cancer Centre, AustraliaSt Vincent's Hospital, SydneyRecruitingProstate CancerAustralia
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostatic Adenocarcinoma | Castration Levels of TestosteroneUnited States, Switzerland, Mexico, Chile, Colombia
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
BayerOrion Corporation, Orion PharmaCompletedMetastatic Hormone-sensitive Prostate CancerBelgium, France, Sweden, China, Canada, United States, Spain, Taiwan, Japan, Finland, Korea, Republic of, Australia, Brazil, Czechia, Israel, Italy, Netherlands, Russian Federation, Bulgaria, United Kingdom, Germany, Poland, Mexico
-
DisperSol Technologies, LLCTranslational Drug DevelopmentActive, not recruiting
-
Medical University of South CarolinaTerminatedProstate CancerUnited States
-
SonaCare MedicalUnknownProstate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States, Canada
-
AstraZenecaParexelCompleted
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, Australia; Novartis Pharmaceuticals and other collaboratorsCompletedProstate CancerAustralia, New Zealand
-
Medical University of South CarolinaRecruitingProstate CancerUnited States
-
Medical University of South CarolinaActive, not recruiting
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
VA Office of Research and DevelopmentRecruitingMetastatic Prostate CancerUnited States
-
Medical University of South CarolinaRecruitingProstate CancerUnited States
-
Medical University of South CarolinaCompletedProstate CancerUnited States
-
AstraZenecaCompletedProstate CancerUnited Kingdom, Germany, United States
-
VA Office of Research and DevelopmentMedical University of South CarolinaCompletedProstate CancerUnited States
-
St Vincent's Hospital, SydneyClarity Pharmaceuticals LtdCompleted
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate CancerUnited States, Canada
-
University of Colorado, DenverBoston Scientific CorporationTerminated
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; Columbia University; Duke University; Lithuanian University... and other collaboratorsCompletedProstate CancerUnited States, Canada, Lithuania
-
LTN PHARMACEUTICALS, INC.CompletedProstate CancerUnited States
-
Prostate Cancer Clinical Trials ConsortiumRecruitingProstate CancerUnited States, Australia, Spain, Switzerland, United Kingdom, Kenya, Canada, Ireland, Barbados, Brazil, Jamaica, Nigeria, Norway, Sweden, South Africa
-
Pellficure Pharmaceuticals, IncTerminatedProstate CancerUnited States, Australia
-
Progenics Pharmaceuticals, Inc.Completed
-
PRAECIS Pharmaceuticals Inc.CompletedProstate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States, Canada
-
Royal North Shore HospitalRecruitingProstate CancerAustralia
-
Dana-Farber Cancer InstituteJanssen Scientific Affairs, LLCActive, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Carcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States, Ireland
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
AstraZenecaBayerRecruitingMetastatic Prostate CancerItaly, United Kingdom, Australia, United States
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticCanada, United States, France, United Kingdom
-
Aptevo TherapeuticsCompletedProstate CancerUnited States, Australia
-
Inovio PharmaceuticalsCompletedProstate CancerUnited States
-
University of Cape TownUnknownBiliary Stricture | Cancer of the Pancreas | Bile Duct Obstruction, Extrahepatic | Cancer of the Bile DuctSouth Africa
-
NRG OncologyNational Cancer Institute (NCI)RecruitingStage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate CancerUnited States, Guam
-
VA Office of Research and DevelopmentSanofiCompletedProstate CancerUnited States, Puerto Rico
-
Christopher Sweeney, MBBSEli Lilly and Company; Walther Cancer InstituteCompletedProstate CancerUnited States
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaboratorsRecruitingProstate Cancer | Radiotherapy Side EffectDenmark
-
AmgenActive, not recruitingNeuroendocrine Prostate CancerBelgium, United States, Austria, Spain, Australia, Netherlands, France, United Kingdom, Japan
-
Central European Cooperative Oncology GroupTerminatedProstate CancerMontenegro, Slovenia, Serbia, Russian Federation, Austria, Poland, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Lithuania, Romania, Slovakia, South Africa
-
Trans Tasman Radiation Oncology GroupAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Urological...Active, not recruiting
-
GlaxoSmithKlineCompletedNeoplasms, ProstateUnited States, Australia, France, Germany, Spain, Bulgaria, Estonia, Italy, Poland, Netherlands, Belgium, United Kingdom, Canada, Denmark, Ukraine, Finland, Latvia, Russian Federation, Greece, Slovenia, Brazil, Mexico, Slovakia, Japan, Puerto... and more